INFINIUM — Infinium Pharmachem Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapNeutral

Annual income statement for Infinium Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	388	705	991	1,142	1,356
Cost of Revenue
Gross Profit	87	157	224	337	314
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	369	662	897	995	1,198
Operating Profit	19	43	94	147	159
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12.4	37.7	86.3	130	152
Provision for Income Taxes
Net Income After Taxes	8.68	27.3	66.9	98.2	115
Minority Interest
Net Income Before Extraordinary Items
Net Income	9.34	27.2	61.1	94.9	113
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9.34	27.2	61.1	94.9	113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.671	1.96	4.39	9.33	8.12